Philip Comp is an Oncology physician affiliated with University of Oklahoma Medical Center. OpenAlex indexes 75 publications with 3,986 citations (h-index 25); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 NE 10th St
Oupb 5200
Oklahoma City, OK 731045417
Telephone
405-271-8299Registry record last updated 3 Jul 2008.
Clinical trials
- Protein S and Myocardial Infarction
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20255 payments
- Merck Sharp & Dohme LLCProgram year20252 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
64.2%Factor Xa inhibitor32.8%Eliquis100%Part D<11 patientsVitamin K antagonist31.3%Warfarin Sodium100%Part D<11 patientsCancer & immunology
35.8%Antimetabolite35.8%Hydroxyurea100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1985–2015 per NIH RePORTER. The latest:
- Environmental Housing with Automatic Watering System
Oklahoma City Va Medical Center
FY2015IS1BX003088 - IMPROVED REAGENTS TO MONITOR ORAL ANTICOAGULATION
University of Oklahoma Hlth Sciences Ctr
FY2006$925M01RR014467 - IMPROVED REAGENTS TO MONITOR ORAL ANTICOAGULATION
University of Oklahoma Hlth Sciences Ctr
FY2005$14,775M01RR014467
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- PFA-100 System: A New Method for Assessment of Platelet Dysfunction
Seminars in Thrombosis and Hemostasis
2023 - Hemophilic Pseudotumor: A Case Report and Review of Literature
International Journal of Clinical Medicine
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Raymond Siatkowski, MD
University of Oklahoma Medical Center
Shinobu Itagaki, MD
University of Oklahoma Medical Center
Timothy Mapstone, MD
University of Oklahoma Medical Center
Parasuram Melarcode Krishnamoorthy, MD
University of Oklahoma Medical Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”